NLS Pharmaceutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%), etc.
NLS Pharmaceutics | SC 13G/A:超過5%持股股東披露文件(修正)-YA II PN, Ltd.(9.99%),YA Global Investments II (U.S.), LP(9.99%)等
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。